FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to medical microbiology, and aims at laboratory or experimental studies in studying antibiotic susceptibility of cholera vibrios. To increase the sensitivity of cholera vibrios to antibacterial drugs, an agent which reduces expression of genes to antibiotic resistance is used. Diclofenac 500 mg/l is used as an expression agent.
EFFECT: use of the invention allows higher sensitivity of cholera vibrios to antibacterial preparations in their combined application with diclofenac in relation to antibiotic resistance cholera vibrio strains in vitro and vivo.
5 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSMENT OF CHOLERA VIBRIO BIOFILMS SENSITIVITY TO ANTIBACTERIAL DRUGS | 2015 |
|
RU2628098C2 |
METHOD FOR ASSESSING LOCAL HUMORAL ANTICHOLERAIC IMMUNITY IN VITRO SIMULATED IN EXPERIMENTAL ANIMALS | 2013 |
|
RU2536707C1 |
METHOD FOR SUPPRESSING THE ADHESIVE PROPERTIES OF CHOLERA VIBRIO | 2020 |
|
RU2763400C1 |
AVIRULENT STRAIN VIBRIO CHOLERAE OF NON 01-SEROGROUP (VARIANTS), METHOD OF STRAIN PREPARING (VARIANTS), VACCINE | 1994 |
|
RU2140981C1 |
"ANTIBAC" - AN INHIBITOR OF PATHOGENIC BACTERIA GROWTH | 1996 |
|
RU2120295C1 |
CHOLERA PROPHYLAXIS METHOD USING VESICLES TO MODEL CHOLERA IMMUNITY IN RESEARCH ANIMALS | 2022 |
|
RU2792160C1 |
AVIRULENT STRAIN OF Vibrio cholerae KM 263 BACTERIA OF SEROVAR INABA OF BIOVAR ELTOR - PRODUCER OF PROTECTIVE O1 ANTIGEN | 2010 |
|
RU2425867C1 |
CULTIVATED HYBRID CELL STRAIN OF Mus musculus L ANIMALS - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO O-ANTIGENE OF CHOLERA VIBRIO SEROGROUP O1 | 2010 |
|
RU2425874C1 |
AVIRULENT STRAIN OF Vibrio cholerae KM 262 BACTERIA OF SEROVAR OGAWA OF BIOVAR ELTOR - PRODUCER OF PROTECTIVE O1 ANTIGEN | 2010 |
|
RU2425868C1 |
METHOD FOR ASSESSING CLINICAL EFFICACY OF ANTIBACTERIAL PREPARATIONS FOR SPECIAL DANGER INFECTIOUS AGENTS Francisella tularensis AND Brucella spp | 2009 |
|
RU2417376C2 |
Authors
Dates
2019-05-20—Published
2018-07-02—Filed